Lowenstein's representation of Provention Bio, Inc., (Nasdaq: PRVB) in its underwritten public offering, which grossed approximately $110 million, is highlighted in the Global Legal Chronicle. The Lowenstein deal team includes Michael J. Lerner, Steven M. Skolnick, James C. Shehan, Sarah P. Cole, and Timothy N. MacKayView Lowenstein's news announcement about this transaction.